Literature DB >> 16186081

Methadone dosage and retention: an examination of the 60 mg/day threshold.

Thomas M Brady1, Sameena Salvucci, Lev S Sverdlov, Alisa Male, Hannah Kyeyune, Emmanuel Sikali, Sameer DeSale, Ping Yu.   

Abstract

A National Institutes of Health (NIH) expert panel has mentioned a daily methadone dose of at least 60 mg as a best practice in methadone maintenance. The focus of this research is to estimate the percentage of outpatient methadone clients receiving this level of methadone and examine the association between treatment retention and level of methadone dosage as recommended by the NIH expert panel. A sample of 428 methadone clients discharged from methadone treatment facilities from the Alcohol and Drug Services Study (ADSS) was used, representing 109,973 methadone clients nationally. It was estimated that more than two-thirds of methadone clients nationally were receiving below 60 mg/day. While controlling for a number of client and organizational variables, a daily methadone dose of 60 mg/day or above was found to be associated with longer retention in treatment. Exploring factors affecting the utilization of the recommended daily methadone dose remains an important issue in effective delivery of methadone treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186081     DOI: 10.1300/J069v24n03_03

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  15 in total

1.  Profile of clients attending a methadone clinic.

Authors:  Sabrina Anne Jacob; Fauziah Mohammed; Mohamed Azmi Ahmad Hassali
Journal:  Malays J Med Sci       Date:  2015 Jan-Feb

2.  Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania.

Authors:  Omary Ubuguyu; Olivia C Tran; Robert Douglas Bruce; Frank Masao; Cassian Nyandindi; Norman Sabuni; Sheryl McCurdy; Jessie Mbwambo; Barrot H Lambdin
Journal:  Int J Drug Policy       Date:  2016-03-11

3.  Predictors of methadone treatment retention from a multi-site study: a survival analysis.

Authors:  Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2011-02-09       Impact factor: 4.492

4.  Demographic and clinical factors predicting retention in methadone maintenance: results from an Irish cohort.

Authors:  C D Darker; J Ho; G Kelly; L Whiston; J Barry
Journal:  Ir J Med Sci       Date:  2015-05-31       Impact factor: 1.568

5.  Pharmacotherapy in the treatment of addiction: methadone.

Authors:  Mary Jeanne Kreek; Lisa Borg; Elizabeth Ducat; Brenda Ray
Journal:  J Addict Dis       Date:  2010-04

6.  Correlates of methadone client retention: a prospective cohort study in Guizhou province, China.

Authors:  Enwu Liu; Tao Liang; Limei Shen; Huan Zhong; Bing Wang; Zunyou Wu; Roger Detels
Journal:  Int J Drug Policy       Date:  2008-10-31

7.  The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs.

Authors:  Jemima A Frimpong; Karen Shiu-Yee; Thomas D'Aunno
Journal:  Health Serv Res       Date:  2016-09-12       Impact factor: 3.402

8.  Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers.

Authors:  Karen D Ersche; Paul C Fletcher; Jonathan P Roiser; Tim D Fryer; Mervyn London; Trevor W Robbins; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2006-09-05       Impact factor: 4.530

9.  Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy.

Authors:  Nasir Mohamad; Nor Hidayah Abu Bakar; Nurfadhlina Musa; Nazila Talib; Rusli Ismail
Journal:  Harm Reduct J       Date:  2010-12-17

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.